[ad_1]
Millions of units of the possible coronavirus vaccine being tested in Germany could be produced by the end of the year, CNN reported. A biotech company in Germany launched the first human clinical trials for a possible COVID-19 vaccine.
The vaccine was prepared by a German company that works with the American pharmaceutical giant Pfizer.
The company says it will begin testing the experimental vaccine in the United States next week and said the vaccine could be ready for emergency use as early as fall, the Wall Street Journal reported.
Mainz-based BioNTech reports that the first group of participants received doses of a potential vaccine called BNT162 for an initial phase clinical trial.
“Twelve study participants have been vaccinated with the BNT162 vaccine in Germany since the start of the study, which started on April 23, 2020,” the company said.
No results available so far. BioNTech stated that approximately 200 healthy volunteers between the ages of 18 and 55 will receive doses in the range of 1 µg (microgram) to 100 µg to find the optimal dose for further studies.
“The safety and immunogenicity of the vaccine will also be examined,” added the biotech company.
“Pfizer” and “BioNTech” plan to start testing BNT162 in the US. USA For approval by the US regulator. USA, which is expected soon, according to the statement. The German Federal Institute for Vaccines and Biomedical Medicines approved the country’s first clinical trial of the COVID-19 vaccine on April 22.
“The two companies plan to jointly conduct clinical trials of the potential COVID-19 vaccine, initially in Europe and the United States, at multiple research sites,” Pfizer announced in its first-quarter report, published online.
“The companies estimate the potential to deliver millions of doses of the vaccine by the end of 2020, with the technical success of the regulatory approval and development program. There is the potential to rapidly increase production capacity to hundreds of millions of doses by 2021.” .
Pfizer is not the only research group conducting clinical trials for a coronavirus vaccine. Last week, scientists at the Jenner Institute at Oxford University in the UK started testing their vaccine for humans. Depending on the test results, Jenner may be ready for the vaccine as early as September.
[ad_2]
